3050 companies

Panbela Therapeutics

Market Cap: US$242.7k

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

PBLA

US$0.05

7D

-66.7%

1Y

-85.7%

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

ALID

US$0.011

7D

0%

1Y

-87.5%

Genomics BioSci & Tech.Ltd

Market Cap: NT$1.8b

Operates as a genomic company in Taiwan.

4195

NT$24.95

7D

1.6%

1Y

37.8%

Guangxi Wuzhou Zhongheng Group

Market Cap: CN¥8.7b

Researches, develops, manufactures, and sells pharmaceuticals in China.

600252

CN¥2.73

7D

1.5%

1Y

45.2%

TiumBio

Market Cap: ₩156.7b

A drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases.

A321550

₩5,670.00

7D

6.8%

1Y

3.1%

Hubei Goto BiopharmLtd

Market Cap: CN¥2.5b

Engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally.

300966

CN¥22.15

7D

2.0%

1Y

55.4%

Bioneer

Market Cap: ₩377.6b

Operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally.

A064550

₩14,460.00

7D

0.6%

1Y

-43.1%

Shaanxi Kanghui Pharmaceutical

Market Cap: CN¥2.4b

Engages in the research and development, production, and sale of pharmaceutical products in China.

603139

CN¥23.81

7D

2.9%

1Y

102.1%

Vicapsys Life Sciences

Market Cap: US$57.3m

Focuses on the development and commercialization of VICAPSYN, a proprietary product.

VICP

US$1.77

7D

0%

1Y

-34.9%

ZYUS Life Sciences

Market Cap: CA$50.8m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

ZYUS

CA$0.65

7D

-5.8%

1Y

-30.1%

Greater Cannabis Company

Market Cap: US$270.0k

Engages in the development and commercialization of cannabinoid therapeutics.

GCAN

US$0.0002

7D

0%

1Y

-71.4%

Breeze Holdings Acquisition

Market Cap: US$1.1b

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.

YDES

US$15.55

7D

13.9%

1Y

38.3%

Rapid Dose Therapeutics

Market Cap: CA$21.3m

A life sciences company, provides drug delivery technologies in Canada.

DOSE

CA$0.16

7D

-5.9%

1Y

14.3%

BeyondSpring

Market Cap: US$78.2m

A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

BYSI

US$1.94

7D

6.0%

1Y

-7.2%

PreveCeutical Medical

Market Cap: CA$20.0m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

PREV

CA$0.035

7D

0%

1Y

133.3%

Chimin Health Management

Market Cap: CN¥6.6b

Researches, develops, produces, and sells human medicines and medical devices in China and internationally.

603222

CN¥12.78

7D

22.1%

1Y

131.5%

3billion

Market Cap: ₩196.0b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩6,200.00

7D

-0.6%

1Y

n/a

Recce Pharmaceuticals

Market Cap: AU$138.8m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

RCE

AU$0.44

7D

3.5%

1Y

-13.7%

HanchorBio

Market Cap: NT$9.5b

Operates as a biotechnology company that develops biologics for cancer patients.

7827

NT$78.00

7D

1.3%

1Y

n/a

Hangzhou Bio-Sincerity Pharma-TechLtd

Market Cap: CN¥6.7b

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

301096

CN¥61.46

7D

-2.2%

1Y

72.5%

LabGenomics

Market Cap: ₩168.5b

Engages in the research and development of biotechnology products in South Korea.

A084650

₩2,310.00

7D

3.8%

1Y

-22.0%

ABION

Market Cap: ₩150.2b

Operates as a pharmaceutical biotech Company in South Korea and internationally.

A203400

₩5,130.00

7D

-6.9%

1Y

-34.2%

IT-ChemLtd

Market Cap: ₩221.7b

IT-CHEM Co., Ltd. develops and manufactures materials for the pharmaceutical and display markets.

A309710

₩17,860.00

7D

-10.2%

1Y

n/a

JS Link

Market Cap: ₩501.2b

A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

A127120

₩17,560.00

7D

-0.7%

1Y

475.7%

Ecofibre

Market Cap: US$366.6k

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

EOFB.F

US$0.001

7D

0%

1Y

-93.3%

Filament Health

Market Cap: US$5.2m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

FLHL.F

US$0.02

7D

0%

1Y

-50.0%

Cresanto Global

Market Cap: ₹15.6m

Does not have significant operations.

531207

₹3.65

7D

0%

1Y

39.3%

Genomtec

Market Cap: zł91.3m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł6.14

7D

-2.8%

1Y

-25.0%

America Great Health

Market Cap: US$12.7m

Operates as a biotechnology company in the United States.

AAGH

US$0.0006

7D

-14.3%

1Y

-78.6%

BioNTech

Market Cap: US$24.5b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

BNTX

US$102.09

7D

1.5%

1Y

1.5%

NovelStem International

Market Cap: US$843.9k

A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

NSTM

US$0.018

7D

0%

1Y

n/a

Tempus AI

Market Cap: US$14.1b

Operates as a healthcare technology company.

TEM

US$81.01

7D

3.4%

1Y

79.8%

Manhattan Scientifics

Market Cap: US$559.0

A technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States.

MHTX

US$0.000001

7D

0%

1Y

-99.9%

CNBX Pharmaceuticals

Market Cap: US$221.6k

A clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.

CNBX

US$0.0004

7D

-20.0%

1Y

-94.3%

NAVCO Pharmaceuticals

Market Cap: CA$285.3k

Develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.

NAV

CA$0.005

7D

0%

1Y

-90.9%

SK bioscienceLtd

Market Cap: ₩3.8t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

A302440

₩48,750.00

7D

-0.8%

1Y

-8.9%

Page 69 of 85